There are two companies here - Generex and NGIO.
Post# of 36537
Excellagen, the medical deals in Arizona, Florida, Ohio and other states are all under Generex. They will remain under Generex, long after NGIO gets listed. This will affect Generex now and into the future.
This should be affecting the PPS now, not when NGIO gets listed or when the vaccine happens, or when the IND gets listed or approved or whatever.
And this is the problem I have right now and I keep going back to it and I know others on the board might look at it differently. But in the 10-Q, they specifically said they were getting funds for these or had them. This should at the very least be in a PR or in an one of the interviews Joe talks about when he does his vaccine talks. This is about Generex having money coming in NOW, not 6 months from now when trials are successful and a vaccine is out there or whatever, but they have funds now. They have a gift given to them that they wrote in a 10-Q and nothing. It's like they mentioned on a CC a few years ago where they said they expected several hundred million dollars per year in excellagen sales or whatever and then nothing. Nada, zilch.
Where is everything they talk about? Is it talk or is it actually there?